DAPAGLIFLOZIN MARKET

INTRODUCTIONDAPAGLIFLOZIN MARKET

Dapagliflozin prevents blood sugar absorption by working in the kidneys. This lowers the level of blood sugar. Metformin decreases the release of stored sugar from the liver, decreases the absorption of sugar from the stomach, and improves how well your body uses sugar.

The principal use of Dapagliflozin Heart failure can also be treated with it. If you are unable to take metformin and have type 2 diabetes, dapagliflozin is typically given.

Dapagliflozin lessens the amount of effort your heart must exert to pump blood throughout your body if you have heart failure. Breathlessness, exhaustion, and swelling in your lower legs are some of the symptoms of heart failure that are alleviated by doing this. Additionally, it lessens the possibility of your heart being weaker.

taking dapagliflozin tablets without first consulting your doctor. If you stop taking it suddenly, your diabetes or heart failure may get worse. Speak to your doctor if this medication isn't doing the job for you or if any side effects are bothering you.

 Two medications have been licenced for the treatment of diabetes: metformin and dapagliflozin. Some studies have suggested that metformin may cause weight loss in addition to its effects on glucose. In diabetic patients on dapagliflozin therapy, there is a small but long-lasting weight loss.

DAPAGLIFLOZIN MARKET SIZE AND FORECAST

The Global DAPAGLIFLOZIN market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

DAPAGLIFLOZIN MARKETNEW PRODUCT LAUNCH

To expand patient access, New Delhi-based pharmaceutical company Zydus Healthcare said that it has introduced generic anti-diabetic Dapagliflozin pills across the nation under the brand name "Dapaglyn" at a very reasonable price.

Following the product's patent expiration, the business released its Dapagliflozin tablets in India in two strengths: 10 mg and 5 mg, priced at respectively.

the pharmaceutical company Zydus Healthcare said that it has expanded patient access by introducing generic anti-diabetic Dapagliflozin pills across the nation under the brand name "Dapaglyn" at a very reasonable price.

The drug will be extremely cost-effective, with a price that is 1/3 less than that of the Dapagliflozin brands already offered in India, in keeping with its aim to make therapies available and cheap to patients, it continued. According to Zydus Healthcare, the once-daily tablets are recommended as a supplement to a healthy diet and regular exercise to help persons with Type 2 diabetes mellitus better regulate their blood sugar levels.

DAPAGLIFLOZIN MARKETCOMPANY PROFILE

• Morepen Laboratories Ltd.
• Solfyn International LLP.
• SENOVA Technology Co., Ltd.
• Shandong Octagon Chemicals Limited.
• Apino Pharma Co., Ltd.

THISDAPAGLIFLOZIN MARKETREPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many DAPAGLIFLOZIN are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global DAPAGLIFLOZIN and key vendor selection criteria
3. Where is the DAPAGLIFLOZIN manufactured? What is the average margin per unit?
4. Market share of Global DAPAGLIFLOZIN market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global DAPAGLIFLOZIN in-house
6. key predictions for next 5 years in Global DAPAGLIFLOZIN market
7. Average B-2-B DAPAGLIFLOZIN market price in all segments
8. Latest trends in DAPAGLIFLOZIN market, by every market segment
9. The market size (both volume and value) of the DAPAGLIFLOZIN market in 2024-2030 and every year in between?
10. Production breakup of DAPAGLIFLOZIN market, by suppliers and their OEM relationship